文献速递耳科与耳神经睡眠呼吸障碍

突发性聋治疗后遗留慢性耳鸣的5年远期疗效观察

[Observation of 5-year long-term efficacy of chronic tinnitus remaining after treatment for sudden deafness].
PubMed 文献 · Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi · 2026-01-01

该回顾性研究纳入210例突聋患者,分析治疗后遗留耳鸣的临床特征及5年远期疗效。资料完整者199例,发病时耳鸣发生率94.0%。5年随访显示总体耳鸣改善率78.6%,显著改善率61.0%,其中38.6%在2周内改善,47.4%在6个月内改善。听力疗效、听力损失类型、睡眠质量和年龄均与耳鸣改善显著相关。

要点

  • 突聋后耳鸣发生率高(94.0%),5年总体改善率78.6%,显著改善率61.0%。
  • 耳鸣改善多发生在治疗后6个月内(2周内38.6%,6个月内47.4%),6个月后趋于平缓。
  • 听力痊愈者耳鸣显著改善率最高(85.4%),中高频听力损失、老年和严重失眠为不利因素。

核心结论

  • 突聋治疗后遗留耳鸣比例较高,可演变为持续5年以上的慢性耳鸣。
  • 大部分患者耳鸣可有不同程度减轻,治疗后6个月内改善最明显,6个月后趋于平缓。
  • 听力疗效可作为评估耳鸣预后的积极指标,累及中高频的听力损失、老龄和严重睡眠障碍是耳鸣改善的不利因素。

研究设计与样本

  • 回顾性分析2017年1月至2020年3月接受治疗的210例突聋患者临床资料。
  • 对治疗后患者随访5年以上,记录治疗前及治疗后2周、6个月、1年、2年、5年的耳鸣情况。
  • 使用耳鸣评价量表(TEQ)和耳鸣残疾量表(THI)评估,按听力损失类型、听力疗效、失眠严重程度指数(ISI)和年龄分组。
  • 统计采用描述性分析,组间比较应用卡方检验,使用SPSS 22.0软件。

主要发现

  • 199例资料完整患者中,94.0%(187/199)发病时伴有耳鸣。
  • 5年后总体耳鸣改善率78.6%(147/187),显著改善率(含痊愈)61.0%(114/187)。
  • 显著改善的114例中,38.6%(44/114)在2周内改善,47.4%(54/114)在6个月内改善,12.3%(14/114)在1年内改善,0.9%(1/114)在第2年改善,0.9%(1/114)在第5年改善。
  • 5年轻度改善率17.7%(33/187),21.4%(40/187)耳鸣无明显改善。

关键数值与推荐

  • 低频下降型、高频下降型、平坦下降型、全聋型的耳鸣显著改善率分别为78.3%(36/46)、44.4%(8/18)、58.0%(40/69)、55.6%(30/54),组间差异有统计学意义(χ2=8.77,P=0.032)。
  • 听力痊愈组、显效组、有效组、无效组的耳鸣显著改善率分别为85.4%(41/48)、60.9%(14/23)、63.5%(33/52)、40.6%(26/64),组间差异有统计学意义(χ2=27.13,P<0.001)。
  • 无失眠组、轻度失眠组、中重度失眠组的耳鸣显著改善率分别为64.8%(79/122)、61.9%(26/42)、39.1%(9/23),组间差异有统计学意义(χ2=11.73,P=0.009)。
  • 青年组、中年组、老年组的耳鸣显著改善率分别为74.2%(66/89)、53.9%(21/39)、45.8%(27/59),组间差异有统计学意义(χ2=15.60,P=0.004)。

临床怎么用

  • 对突聋后遗留耳鸣患者,应告知多数可在6个月内改善,6个月后趋于稳定。
  • 听力恢复情况可用于预测耳鸣预后,听力痊愈者耳鸣改善可能性更高。
  • 对伴有中高频听力损失、高龄或严重睡眠障碍的患者,应加强耳鸣康复管理。

局限性

  • 本研究为单中心回顾性分析,样本量有限(资料完整者199例)。
  • 耳鸣评估依赖患者填写量表,可能存在主观偏倚。
  • 随访期间未控制可能影响耳鸣的其他干预因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To further clarify the clinical characteristics and 5-year long-term efficacy observation of chronic tinnitus left over after treatment for sudden deafness. Method: A retrospective analysis was conducted on the clinical data of 210 patients with sudden deafness who received treatment from January 2017 to March 2020. The incidence, clinical characteristics, and treatment effects of tinnitus were explored. Patients after treatment were followed up for more than 5 years. Through investigation and regular follow-up, the situation before the start of treatment and 2 weeks, 6 months, 1 year, 2 years, and 5 years after treatment was recorded. Patients were required to fill out the survey information collection form, Tinnitus Evaluation Questionnaire (TEQ), and Tinnitus Disability Inventory (THI). Among the 210 patients, they were divided into low-frequency decline type, high-frequency decline type, flat decline type, and total deafness type according to different types of hearing loss. They were divided into four groups based on hearing efficacy: the cured, significantly effective, effective, and ineffective. According to the patient's sleep condition, they were divided into three groups based on the Insomnia Severity Index (ISI) score: non-insomnia group, mild insomnia group and moderate to severe insomnia group. According to age groups, they were divided into youth group (18-44 years old), middle-aged group (45-59 years old), and elderly group (over 60 years old). Descriptive analysis method was used, and Chi-square test was applied between groups. SPSS 22.0 software was used to analyze the data. Results: Among the 210 patients, 199 had complete data, including 113 males and 86 females. The age range of the patients was between 25 and 90 years old, with an average age of 50.6 years. Among them, 94.0% (187/199) of patients had tinnitus symptoms at the time of onset. A 5-year follow-up showed that the overall improvement rate of tinnitus was 78.6% (147/187) after 5 years, with a significant improvement rate (including recovery) of 61.0% (114/187). Among the 114 patients who showed significant improvement, 38.6% (44/114) improved within 2 weeks, 47.4% (54/114) improved within 6 months, 12.3% (14/114) improved within 1 year, 0.9% (1/114) improved in the second year, 0.9% (1/114) improved in the fifth year, and the 5-year mild improvement rate was 17.7% (33/187). 21.4% of patients (40/187) had no significant improvement in tinnitus symptoms. Among different types of hearing loss, the significant improvement rates of tinnitus in the low-frequency decline type, high-frequency decline type, flat decline type, and total deafness type were 78.3% (36/46), 44.4% (8/18), 58.0% (40/69), and 55.6% (30/54), respectively, with statistically significant differences between groups (χ2=8.77, P=0.032). Among the groups with different hearing therapy effects, the significant improvement rates of tinnitus in the hearing recovery group [85.4% (41/48)], significant improvement group [60.9% (14/23)], effective group [63.5% (33/52)], and ineffective group [40.6% (26/64)] were statistically significant (χ2=27.13, P<0.001). Specifically, the difference between the hearing recovery group and the hearing significant improvement group was statistically significant (χ2=7.24, P=0.027); the difference between the hearing recovery group and the hearing effective group was statistically significant (χ2=9.34, P=0.009); and the difference between the hearing recovery group and the hearing ineffective group was statistically significant (χ2=25.96, P<0.001). Among different sleep quality groups, the significant improvement rates of tinnitus in the non-insomnia group [64.8% (79/122)], mild insomnia group [61.9% (26/42)], and moderate to severe insomnia group [39.1% (9/23)] were statistically significant (χ2=11.73, P=0.009). The difference between the moderate to severe insomnia group and the non-insomnia group was statistically significant (χ2=9.16, P=0.010); the difference between the moderate to severe insomnia group and the mild insomnia group was statistically significant (χ2=6.37, P=0.041); and the difference between the mild insomnia group and the non-insomnia group was not statistically significant (χ2=2.49, P=0.288); Among different age groups, there was a statistically significant difference in the significant improvement of tinnitus between the youth group [74.2% (66/89)], the middle-aged group [53.9% (21/39)], and the elderly group [45.8% (27/59)] (χ2=15.60, P=0.004). Specifically, the difference between the youth group and the elderly group was statistically significant (χ2=14.73, P=0.001); the difference between the middle-aged group and the elderly group was also statistically significant (χ2=6.68, P=0.035). Conclusion: The incidence of residual tinnitus after sudden deafness treatment is high, and it eventually evolves into chronic tinnitus, which can last for more than 5 years. Most patients can experience varying degrees of relief and improvement. The improvement of tinnitus is most significant within 6 months after treatment, and it tends to flatten out after 6 months. The effect of hearing therapy can be used as a positive indicator to predict the prognosis of tinnitus. Multi frequency hearing loss involving middle and high frequencies, elderly people, and severe sleep disorders are unfavorable factors for the rehabilitation of tinnitus. 目的: 进一步明确突发性聋(突聋)治疗后长期遗留慢性耳鸣患者的临床特征和5年远期疗效。 方法: 回顾性分析2017年1月至2020年3月接受治疗的210例突聋患者的临床资料,探讨耳鸣的发生情况、临床特征及其治疗效果,对治疗后患者进行长达5年以上的随访,通过调查和定期随访,记录治疗开始前及治疗后2周、6个月、1年、2年、5年的耳鸣情况,要求患者填写调查信息采集表、耳鸣评价量表(Tinnitus Evaluation Questionnaire,TEQ)及耳鸣残疾量表(Tinnitus Disability Inventory,THI)。依据不同听力损失类型,将患者分为低频下降型、高频下降型、平坦下降型和全聋型四组;依据听力疗效分为治愈、显效、有效和无效四组;根据失眠严重程度指数(insomnia severity index,ISI)得分分为无失眠组、轻度失眠组和中重度失眠组;根据年龄段分青年组(18~44岁)、中年组(45~59岁)和老年组(60岁及以上)。统计采用描述性分析方法,组间比较应用卡方检验,以SPSS 22.0软件对数据进行分析。 结果: 210例突聋患者中,资料完整者199例,其中男性113例、女性86例,年龄25~90岁,平均年龄50.6岁。199例患者中94.0%(187/199)发病时伴有耳鸣症状。为期5年的跟踪随访显示,5年后总体耳鸣改善率达78.6%(147/187),其中耳鸣显著改善率(含痊愈)达61.0%(114/187)。在显著改善的114例患者中,38.6%(44/114)在2周内改善,47.4%(54/114)在6个月内改善,12.3%(14/114)在1年内改善,0.9%(1/114)在第2年改善,0.9%(1/114)在第5年改善。5年轻度改善率为17.7%(33/187),21.4%的患者(40/187)耳鸣症状无明显改善。不同听力损失类型中,低频下降型、高频下降型、平坦下降型、全聋型的耳鸣显著改善率分别为78.3%(36/46)、44.4%(8/18)、58.0%(40/69)和55.6%(30/54),组间比较差异具有统计学意义(χ2=8.77,P=0.032)。不同听力疗效分组中痊愈组[85.4%(41/48)]、显效组[60.9%(14/23)]、有效组[63.5%(33/52)]、无效组[40.6%(26/64)]的耳鸣显著改善情况,组间比较差异具有统计学意义(χ2=27.13,P<0.001);其中听力痊愈组与听力显效组比较,差异具有统计学意义(χ2=7.24,P=0.027);听力痊愈组与听力有效组比较,差异具有统计学意义(χ2=9.34,P=0.009);听力痊愈组与听力无效组比较,差异具有统计学意义(χ2=25.96,P<0.001)。不同睡眠质量分组中,无失眠组[64.8%(79/122)]、轻度失眠组[61.9%(26/42)]、中重度失眠组[39.1%(9/23)]耳鸣显著改善情况比较,组间差异具有统计学意义(χ2=11.73,P=0.009);中重度失眠组与无失眠组相比,差异具有统计学意义(χ2=9.16,P=0.010);中重度失眠组与轻度失眠组相比,差异具有统计学意义(χ2=6.37,P=0.041);轻度失眠组与无失眠组相比,差异无统计学意义(χ2=2.49,P=0.288)。不同年龄段分组中,青年组[74.2%(66/89)]、中年组[53.9%(21/39)]及老年组[45.8%(27/59)]耳鸣显著改善情况组间比较,差异有统计学意义(χ2=15.60,P=0.004);其中青年组与老年组相比,差异具有统计学意义(χ2=14.73,P=0.001);中年组与老年组相比,差异具有统计学意义(χ2=6.68,P=0.035)。 结论: 突聋患者治疗后遗留耳鸣的比例较高,并最终演化成慢性耳鸣,可持续5年以上。大部分患者的耳鸣可有不同程度地减轻和改善,治疗后6个月内耳鸣改善最明显,6个月后耳鸣改善趋于平缓。听力疗效可以作为评估耳鸣预后的一个积极指标,累及中高频的听力损失、老龄和严重睡眠障碍是耳鸣改善的不利因素。.

来源:Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Peng X, Liu MB, Huang BQ, et al. [Observation of 5-year long-term efficacy of chronic tinnitus remaining after treatment for sudden deafness]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2026. PMID: 41673962. doi:10.3760/cma.j.cn115330-20250421-00240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。